Our Clinical Trials Experience
Contribution
Over 310 patients have participated in our research trials in the last 3 years
Experience
Over the last 30 years we have collaborated with over 50 sponsors and conducted over 210 clinical trials
Publications
Dr Lynda Spelman has authored over 70 peer-reviewed publications

Studies
We are currently delivering 32 clinical research trials and studies
Treatments
We have contributed to the development of over 30 PBS approved new treatments
Access
We help patients access approved and developing treatments for chronic inflammatory skin, nail and hair conditions and malignant skin disorders
ABOUT US
​
Veracity Clinical Research is a dermatology clinical research company that conducts clinical research trials in the field of inflammatory skin, nail and hair conditions.
Most legitimate medical treatment breakthroughs are a result of clinical research. At Veracity Clinical Research, we focus on establishing the efficacy of proposed new treatments and management options for skin conditions.
​
We strive to identify better ways of managing skin conditions by:
-
developing new treatments for dermatological disorders,
-
undertaking studies that expand and challenge known facts  about a wide range of  skin disorders, and
-
comparing existing treatments with new management concepts to offer innovative options to trial participants.
​
The Veracity team works to provide successful interventions for a range of dermatological conditions including acne, atopic dermatitis/eczema, chronic plaque psoriasis, hidradenitis suppurativa, superficial basal cell carcinoma, actinic keratosis and more, under the direction of our Principal Investigator Dr Lynda Spelman.
OUR SERVICES
Clinical research trials explore the safety and efficacy of proposed new treatment options while in the treatment's development stages. Veracity Clinical Research conducts a wide range of clinical research trials for numerous skin conditions.
For more information, refer to the current trials section on the website or contact us on +617 3039 1311.  
​


